Net shares · 365d
-72.0K
100.0K buy · 172.0K sell
Net value · 365d
-$5.4M
$713.2K in · $6.2M out
Sentiment · 365d
Net selling
10% buying · 90% selling
Open-market trades · 365d
13
100.0K buy · 172.0K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
PBYI Sell·S
Director · 10b5-1
$77.7K
10.8K sh · $7.20
Own -15%
-
PBYI Grant·A
Director · 10b5-1
$0
27.0K sh
Own +62%
-
KURA Exercise·M
President and CEO
$0
6.1K sh
Own New
-
KURA Exercise·M
President and CEO
$37.5K
6.1K sh · $6.15
Own +1%
-
RNA Grant·A
Director
$0
20.0K sh
Own New
-
RNA Other·D
Director
—
38.5K sh · 3 lots
Own -100%
-
RNA Other·D
Director
—
78.8K sh · 2 lots
Own -100%
-
KURA Grant·A
President and CEO
$0
1.1M sh
Own New
-
KURA Grant·A
President and CEO
$0
182.5K sh
Own +74%
-
KURA Sell·S
President and CEO
$327.3K
36.6K sh · $8.94
Own -13%
-
KURA Grant·A
President and CEO
$0
182.5K sh
Own +181%
-
KURA Buy·P
President & CEO
$410.0K
50.0K sh · $8.20
Own +98%
-
RNA Exercise·M
Director · 10b5-1
$0
14.5K sh
Own New
-
RNA Sell·S
Director · 10b5-1
$1.5M
29.5K sh · $50.00 avg · 2 lots
Own -30%
-
RNA Exercise·M
Director · 10b5-1
$181.0K
14.5K sh · $12.48
Own +21%
-
KURA Buy·P
President and CEO
$303.2K
50.0K sh · $6.06 avg · 2 lots
Own +5165%
-
RNA Exercise·M
Director · 10b5-1
$0
29.5K sh · 2 lots
Own New
-
RNA Sell·S
Director · 10b5-1
$4.3M
95.1K sh · $45.00 avg · 6 lots
Own -84%
-
RNA Exercise·M
Director · 10b5-1
$358.3K
29.5K sh · $12.14 avg · 2 lots
Own +48%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | PBYI | Sell S | 10.8K | $77.7K |
| Jun 11, 2026 | PBYI | Grant A | 27.0K | $0 |
| Mar 23, 2026 | KURA | Exercise M | 6.1K | $0 |
| Mar 23, 2026 | KURA | Exercise M | 6.1K | $37.5K |
| Feb 27, 2026 | RNA | Grant A | 20.0K | $0 |
| Feb 27, 2026 | RNA | Other D | 38.5K3 lots | — |
| Feb 27, 2026 | RNA | Other D | 78.8K2 lots | — |
| Jan 2, 2026 | KURA | Grant A | 1.1M | $0 |
| Nov 13, 2025 | KURA | Grant A | 182.5K | $0 |
| Sep 29, 2025 | KURA | Sell S | 36.6K | $327.3K |
| Sep 27, 2025 | KURA | Grant A | 182.5K | $0 |
| Sep 8, 2025 | KURA | Buy P | 50.0K | $410.0K |
| Sep 5, 2025 | RNA | Exercise M | 14.5K | $0 |
| Sep 5, 2025 | RNA | Sell S | 29.5K2 lots | $1.5M |
| Sep 5, 2025 | RNA | Exercise M | 14.5K | $181.0K |
| Aug 13, 2025 | KURA | Buy P | 50.0K2 lots | $303.2K |
| Aug 6, 2025 | RNA | Exercise M | 29.5K2 lots | $0 |
| Aug 6, 2025 | RNA | Sell S | 95.1K6 lots | $4.3M |
| Aug 6, 2025 | RNA | Exercise M | 29.5K2 lots | $358.3K |
Buy Sell Non-market (grant · exercise · gift)
About WILSON TROY EDWARD
This profile aggregates every SEC Form 4 insider transaction reported by WILSON TROY EDWARD across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.